LAP3 was present in the cytoplasm in the previous studies [12, 16], we discovered that LAP3 was mainly increased in the nucleus of hepatocytes in both the HFD-induced NASH rats and LO2 cells treatment with CHO. This evidence concerns the gene LAP3 and metabolic dysfunction-associated steatohepatitis.